http://www.reportbuyer.com/rss.htmlObtain global insight into Alzheimer's disease markets, information such as Neurodegenerative drug therapies and insight.en-gbReportbuyerservice@reportbuyer.comenquiries@redwiredesign.comhttp://www.reportbuyer.com/pharma_healthcare/diseases/alzheimers/alzheimers_disease.htmlAlzheimer's disease remains a challenge in management. With nearly 8 million sufferers from this condition in the seven major markets of the world and anticipated increases in the future. Considerable research is in progress to understand the pathomechanism of the disease and find a cure. 3b4e9ea0d5fb2ffa62b6131d9a8740ceSat, 10 Oct 2009 12:00:00 GBDiseases/Alzheimer'shttp://www.reportbuyer.com/pharma_healthcare/diseases/alzheimers/alzheimers_disease_markets_pipeline_opportunities_2009.htmlToday's armoury of approved drugs for the treatment of Alzheimer's Disease (AD) largely depends on just five therapeutic agents. In 2007, three of these agents represented 88% of global sales, in a market that this report estimates exceeded $6 billion in 2008. There are presently no cures for AD, and current drugs are only able to treat some of the symptoms in some people, with benefits that are often short-lived. 718ceb4650e1144c4a6cec5490063c2aWed, 01 Apr 2009 12:00:00 GBDiseases/Alzheimer'shttp://www.reportbuyer.com/pharma_healthcare/diseases/alzheimers/china_senile_dementia_drug_market_report.htmlBy conservative estimates, there are about 6 million Chinese senile dementia (SD) patients (including vascular dementia, Alzheimer's disease and other types of dementia patients). It is estimated that there will be 250 million senior Chinese of 60 years or older by the year 2025, and among which there will be 10. 09 million senile dementia patients. 67bcf0d0859ed4d004065e5758d50f59Tue, 03 Mar 2009 12:00:00 GBDiseases/Alzheimer'shttp://www.reportbuyer.com/pharma_healthcare/diseases/alzheimers/global_alzheimer_drugs_market.htmlThe Alzheimer's disease (AD) diagnosis and therapy market is expanding with increasing number of cases worldwide. The current scenario shows bright outlook for diagnosis market. As early diagnosis of AD is not possible, there is a strong need of an early detection technique. 99c5b9113f628a57680125468610e55fTue, 03 Mar 2009 12:00:00 GBDiseases/Alzheimer'shttp://www.reportbuyer.com/pharma_healthcare/diseases/alzheimers/alzheimers_disease_antibodies.htmlProduct description The Competitive Intelligence Report Alzheimer's Disease Antibodies as of July 2008 provides a competitor analysis in the development pipeline of novel antibodies for passive immunotherapy of Alzheimers disease including those targeting amyloid-beta (beta-amyloid). Among the companies active in the field of new antibodies for passive immunotherapy of Alzheimers disease Wyeth, Elan, Pfizer, Roche and many others. The report includes a compilation of current active projects in research and development of novelantibodies for passive immunotherapy of Alzheimers disease. 3aa5533f229e5010845273a060d3b7c9Mon, 07 Jul 2008 12:00:00 GBDiseases/Alzheimer'shttp://www.reportbuyer.com/pharma_healthcare/diseases/alzheimers/diagnostic_therapeutic_trends_alzheimers_disease_technical_insights.htmlThis research service analyses the latest diagnostic and therapeutic developments that have occurred in the Alzheimer's disease sector, both from a technology and industry perspective. . c76a425a5e483352a63270273a9a8b8fFri, 06 Jun 2008 12:00:00 GBDiseases/Alzheimer'shttp://www.reportbuyer.com/pharma_healthcare/diseases/alzheimers/alzheimers_parkinsons_disease.htmlThis report analyzes the worldwide markets for Alzheimer's and Parkinson's Disease in Millions of US$. The Major product segments Analyzed are Anti-Alzheimer's Disease Drugs (Cholinesterase Inhibitors, & NMDARA), and Anti-Parkinson's Disease Drugs (Dopaminergic Agents, Dopamine Agonists, & Other PD Drugs (Include COMT Inhibitors, MOA-B Inhibitors, and Dopamine Amplifiers). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, and Rest of World. 6577c2af5379a5c4657c2b4e73db4bd0Mon, 05 May 2008 12:00:00 GBDiseases/Alzheimer's